论文信息 - RUBY: A phase II study testing rucaparib in germline (g) BRCA wild-type patients presenting metastatic breast cancer (mBC) with homologous recombination deficiency (HRD). - 字舞流文

RUBY: A phase II study testing rucaparib in germline (g) BRCA wild-type patients presenting metastatic breast cancer (mBC) with homologous recombination deficiency (HRD).

I. Bièche | F. André | O. Trédan | N. Droin | M. Sablin | A. Tran-Dien | M. Arnedos | C. Vicier | M. Jimenez | A. Gonçalves | L. Campion | A. Patsouris | W. Gouraud | C. Callens | A. Loehr | D. Nenciu